Dakota Wealth Management’s Anixa Biosciences ANIX Stock Holding History

Dakota Wealth Management’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42K	Hold	15,000	–	–	﹤0.01%	773
2026 Q1	$38.7K	Hold	15,000	–	–	﹤0.01%	763
2025 Q4	$46.8K	Hold	15,000	–	–	﹤0.01%	773
2025 Q3	$49.5K	Hold	15,000	–	–	﹤0.01%	640
2025 Q2	$49.5K	Hold	15,000	–	–	﹤0.01%	758
2025 Q1	$42.9K	Hold	15,000	–	–	﹤0.01%	745
2024 Q4	$34.8K	Hold	15,000	–	–	﹤0.01%	744
2024 Q3	$47.3K	Hold	15,000	–	–	﹤0.01%	724
2024 Q2	$33.1K	Hold	15,000	–	–	﹤0.01%	711
2024 Q1	$46.8K	Hold	15,000	–	–	﹤0.01%	711
2023 Q4	$58.2K	Hold	15,000	–	–	﹤0.01%	648
2023 Q3	$49K	Buy	+15,000	New	+$52.5K	﹤0.01%	646

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Dakota Wealth Management's ANIX Position: Q2 2026 in Review

Dakota Wealth Management held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 15,000 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #773.

Dakota Wealth Management first reported a position in ANIX in Q3 2023 and has held it in 12 quarters since. The position peaked at $58.2K in Q4 2023. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

Dakota Wealth Management held 15,000 shares of Anixa Biosciences worth $42K as of Q2 2026.
Dakota Wealth Management left its Anixa Biosciences share count unchanged in Q2 2026.
Anixa Biosciences made up ﹤0.01% of Dakota Wealth Management's portfolio in Q2 2026, its #773 holding.
Dakota Wealth Management first reported a position in Anixa Biosciences in Q3 2023 and has held it in 12 quarters since.
Dakota Wealth Management's Anixa Biosciences position peaked at $58.2K in Q4 2023.
63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.